The Role of Immunohistochemistry in the Differential Diagnosis between Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma and Liver Metastasis, as Well as Its Prognostic Value
Diagnostics · 25.04.2023 · 13 (9) · 1542
DOI: 10.3390/diagnostics13091542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 25.04.2023. Verfasst von Lavinia Patricia Mocan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intrahepatic cholangiocarcinoma (iCCA) is the second most frequent primary hepatic malignant tumor, after hepatocellular carcinoma (HCC). Its incidence has risen worldwide, yet the only potentially curative treatment, surgical resection, is seldom applicable, and the median overall survival remains extremely low. So far, there are no personalized therapy regimens. This study investigated whether routine immunohistochemical stains have diagnostic and/or prognostic value in iCCA. Clinical, imaging, and pathology data were retrospectively gathered for patients diagnosed with iCCA, HCC, or liver metastases assessed using liver needle biopsies. Three study groups with an equal number of cases (n = 65) were formed. In the iCCA group, CK19, CA19-9, CK7, and CEA demonstrated the highest sensitivities (100%, 100%, 93.7%, and 82.6%, respectively). The most relevant stains used for diagnosing HCCs were Glypican 3, CD34 (sinusoidal pattern), and Hep Par 1, with corresponding sensitivities of 100%, 100%, and 98.2%. The immunohistochemical panels for diagnosing metastatic tumors were chosen after correlating the clinical data and morphologic H&E aspects. Moderate/intensely positive CK7 expression and absent/low amount of intratumoral immune cells were favorable prognostic factors and correlated with increased overall survival in both the univariate analysis and the multivariate regression adjusted for age, existence of cirrhosis, number of tumors, and tumor differentiation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Histology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
- Department of Pathology, "Prof. Dr. Octavian Fodor" Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania.
- UBBMed Department, Babeș-Balyai University, 400347 Cluj-Napoca, Romania.
- Department of Gastroenterology, "Prof. Dr. Octavian Fodor" Regional Institute of Gastroenterology and Hepatology, 400162 Cluj-Napoca, Romania.
- 3rd Medical Department, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400162 Cluj-Napoca, Romania.
- Department of Proteomics and Metabolomics, MedFUTURE Research Center for Advanced Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
ORCID-Profile: Lavinia Patricia Mocan, Bianca Adina Boșca, Maria Iacobescu
Zitieren
APA
Mocan, L. P., Rusu, I., Melincovici, C. S., Boșca, B. A., Mocan, T., Crăciun, R., Spârchez, Z., Iacobescu, M., & Mihu, C. M. (2023). The Role of Immunohistochemistry in the Differential Diagnosis between Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma and Liver Metastasis, as Well as Its Prognostic Value. Diagnostics, 13(9), 1542. https://doi.org/10.3390/diagnostics13091542
Vancouver
Mocan LP, Rusu I, Melincovici CS, Boșca BA, Mocan T, Crăciun R, et al. The Role of Immunohistochemistry in the Differential Diagnosis between Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma and Liver Metastasis, as Well as Its Prognostic Value. Diagnostics. 2023;13(9):1542. doi:10.3390/diagnostics13091542
BibTeX
@article{Mocan2023,
author = {Mocan, Lavinia Patricia and Rusu, Ioana and Melincovici, Carmen Stanca and Boșca, Bianca Adina and Mocan, Tudor and Crăciun, Rareș and Spârchez, Zeno and Iacobescu, Maria and Mihu, Carmen Mihaela},
title = {The Role of Immunohistochemistry in the Differential Diagnosis between Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma and Liver Metastasis, as Well as Its Prognostic Value},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {9},
pages = {1542},
doi = {10.3390/diagnostics13091542}
}
EUVIMED